Capella Space owns a constellation of synthetic aperture radar (SAR) satellites, wholly designed, manufactured and operated in-house. This constellation has been in commercial operation since January ...
On Monday, Halozyme Therapeutics, Inc. (HALO) stock saw a decline, ending the day at $51.77 which represents a decrease of $-0.84 or -1.60% from the prior close of $52.61. The stock opened at $52.6 ...
Halo’s unparalleled connectivity enables Beyond the Visual Line Of Sight (BVLOS) drone flights for authorities to safely monitor inaccessible areas remotely from a control centre.